Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Dermatology | Monthly Briefing

Back to Journal Articles

June 2010 Briefing - Dermatology

Last Updated: July 01, 2010.

 

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for June 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Researchers Identify Genes Behind Alopecia Areata

WEDNESDAY, June 30 (HealthDay News) -- Researchers have identified eight genes that play a role in alopecia areata, an autoimmune disease that affects about 2 percent of the overall population and results in hair loss from the scalp and other areas of the body, and their findings have been published in the July 1 issue of Nature.

Abstract
Full Text (subscription or payment may be required)

Benzoyl Peroxide/Salicylic Acid Wins As Initial Acne Treatment

WEDNESDAY, June 30 (HealthDay News) -- Benzoyl peroxide (BPO) with salicylic acid (SA) works better than BPO with clindamycin (CL) for the initial treatment of acne, but after 10 to 12 weeks there is little difference in results between the two treatments, according to research published in the July issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Papulopustular Rosacea Rate, UV Exposure Not Related

FRIDAY, June 25 (HealthDay News) -- The prevalence of papulopustular rosacea (PPR) in Ireland is nearly 3 percent, though cumulative ultraviolet (UV) radiation exposure does not affect the prevalence of the condition among the country's predominantly fair-skinned population, according to research published in the July issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Many Psoriasis Sufferers Hindered by Insurance Issues

THURSDAY, June 24 (HealthDay News) -- A third of people with psoriasis do not receive adequate treatment for their condition because they lack adequate health care coverage or are unable to meet the copays for treatment, according to results of a survey conducted by the National Psoriasis Foundation.

More Information

Incidence Rate of Rare Skin Carcinoma on the Rise

TUESDAY, June 22 (HealthDay News) -- The incidence rate (IR) for cutaneous appendageal carcinoma (CAC) in the United States is low and varies by sex/ethnic group, but it has been increasing, possibly partly due to increased ultraviolet exposure and improvements in diagnosis, according to research published in the June issue of the Archives of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Some Moist Toilet Paper Can Cause Severe Reaction

TUESDAY, June 22 (HealthDay News) -- A preservative used in moist toilet paper can cause a severe allergic reaction in some people, as demonstrated by four case reports published online June 21 in the Archives of Dermatology.

Abstract
Full Text

Novel Approach Shows Promise for Melanoma Treatment

WEDNESDAY, June 16 (HealthDay News) -- A novel approach using targeted therapy against the BRAF/mitogen-activated protein kinase (MAPK) pathway in combination with immunotherapy holds promise in the treatment of melanoma, according to a preclinical study published online June 15 in Cancer Research.

Abstract
Full Text (subscription or payment may be required)

Effect of UV Exposure on Vitamin D Levels Quantified

TUESDAY, June 8 (HealthDay News) -- Although it may be possible to achieve equivalent doses of vitamin D supplementation with natural sun exposure and oral supplementation, intentional sun exposure may result in serious adverse effects, and oral supplementation is the safest method for increasing vitamin D status, according to a study published in the June issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Triple Combination Cream Reduces Melasma Severity

TUESDAY, June 8 (HealthDay News) -- Although using daily triple combination (TC) cream for 12 weeks is safe and effective in reducing melasma severity enough for patients to reduce administration to twice per week, most patients relapse, requiring resumption of daily therapy, according to a study in the June issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Rural Residents Less Likely to Use Sunscreen

THURSDAY, June 3 (HealthDay News) -- Rural residents are less likely than urban residents to use sunscreen, but this may be explained by confounding factors such as differences in age and income, according to a study in the June issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2010 ScoutNews, LLC. All rights reserved.


Previous: June 2010 Briefing - Cardiology Next: June 2010 Briefing - Diabetes & Endocrinology

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.